Brief Report: The Impact of Disease Stage on Early Gaps in ART in the "treatment for All" Era - A Multisite Cohort Study.

Authors

Ingrid T. Katz, Harvard Medical School
Nicholas Musinguzi, Mbarara University of Science and Technology
Kathleen Bell, University of Cape Town Medical School
Anna Cross, University of Cape Town Medical School
Mwebesa Bosco Bwana, Mbarara University of Science and Technology
Gideon Amanyire, Mbarara University of Science and Technology
Stephen Asiimwe, Mbarara University of Science and Technology
Catherine Orrell, University of Cape Town Medical School,Follow
David R. Bangsberg, OHSU-PSU School of Public HealthFollow
Jessica E. Haberer, Harvard Medical SchoolFollow

Published In

Journal of Acquired Immune Deficiency Syndromes (1999)

Document Type

Article

Publication Date

12-17-2020

Subjects

Real-time monitoring

Abstract

Adoption of "Treat All" policies has increased ART initiation in sub-Saharan Africa; however, unexplained early losses continue to occur. More information is needed to understand why treatment discontinuation continues at this vulnerable stage in care.

Rights

Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.

Locate the Document

https://doi.org/10.1097/QAI.0000000000002605

DOI

10.1097/QAI.0000000000002605

Persistent Identifier

https://archives.pdx.edu/ds/psu/35346

Citation Details

Katz, I. T., Musinguzi, N., Bell, K., Cross, A., Bwana, M. B., Amanyire, G., Asiimwe, S., Orrell, C., Bangsberg, D. R., & Haberer, J. E. (2021). Brief Report: The Impact of Disease Stage on Early Gaps in ART in the “Treatment for All” Era—A Multisite Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 86(5), 562–567. https://doi.org/10.1097/qai.0000000000002605